Revolutionising the treatment of respiratory disease

Traditionally, capnometers have been used in hospitals as an essential tool during anaesthesia and intensive care, to track respiratory failure. Evidence has suggested that capnometry could be used to identify airway obstruction associated with asthma and chronic obstructive pulmonary disease (COPD).

These diseases affect almost 10 percent of the world’s population, with COPD now listed as the third leading cause of death worldwide. This is predominantly driven by smoking and air pollution. Yet, advances in respiratory care management have not kept pace. Late and inaccurate diagnosis of these conditions results in billions of pounds in healthcare costs, through exacerbations leading to hospitalisations, many of which are preventable. 
 
The challenge for Wideblue was to support TidalSense in designing an easy-to-use handheld device which could collect breath waveform data for use in a GP’s surgery or the patient’s home, and securely transmit the data to a remote server. 

Read the full article in DPA's December issue